BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 9407117)

  • 1. A dominant-negative form of transcription factor MEF2 inhibits myogenesis.
    Ornatsky OI; Andreucci JJ; McDermott JC
    J Biol Chem; 1997 Dec; 272(52):33271-8. PubMed ID: 9407117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MEF2 protein expression, DNA binding specificity and complex composition, and transcriptional activity in muscle and non-muscle cells.
    Ornatsky OI; McDermott JC
    J Biol Chem; 1996 Oct; 271(40):24927-33. PubMed ID: 8798771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myocyte enhancer factor 2C and myogenin up-regulate each other's expression and induce the development of skeletal muscle in P19 cells.
    Ridgeway AG; Wilton S; Skerjanc IS
    J Biol Chem; 2000 Jan; 275(1):41-6. PubMed ID: 10617583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transactivation of capn2 by myogenic regulatory factors during myogenesis.
    Dedieu S; Mazères G; Dourdin N; Cottin P; Brustis JJ
    J Mol Biol; 2003 Feb; 326(2):453-65. PubMed ID: 12559913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple roles for the MyoD basic region in transmission of transcriptional activation signals and interaction with MEF2.
    Black BL; Molkentin JD; Olson EN
    Mol Cell Biol; 1998 Jan; 18(1):69-77. PubMed ID: 9418854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcriptional activation of the myogenin gene by MEF2-mediated recruitment of myf5 is inhibited by adenovirus E1A protein.
    Johanson M; Meents H; Ragge K; Buchberger A; Arnold HH; Sandmöller A
    Biochem Biophys Res Commun; 1999 Nov; 265(1):222-32. PubMed ID: 10548518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Permissive roles of phosphatidyl inositol 3-kinase and Akt in skeletal myocyte maturation.
    Wilson EM; Tureckova J; Rotwein P
    Mol Biol Cell; 2004 Feb; 15(2):497-505. PubMed ID: 14595115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activated raf kinase inhibits muscle cell differentiation through a MEF2-dependent mechanism.
    Winter B; Arnold HH
    J Cell Sci; 2000 Dec; 113 Pt 23():4211-20. PubMed ID: 11069766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of the human GLUT4 gene promoter: interaction between a transcriptional activator and myocyte enhancer factor 2A.
    Knight JB; Eyster CA; Griesel BA; Olson AL
    Proc Natl Acad Sci U S A; 2003 Dec; 100(25):14725-30. PubMed ID: 14630949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of the myogenic lineage by MEF2A, a factor that induces and cooperates with MyoD.
    Kaushal S; Schneider JW; Nadal-Ginard B; Mahdavi V
    Science; 1994 Nov; 266(5188):1236-40. PubMed ID: 7973707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutational analysis of the DNA binding, dimerization, and transcriptional activation domains of MEF2C.
    Molkentin JD; Black BL; Martin JF; Olson EN
    Mol Cell Biol; 1996 Jun; 16(6):2627-36. PubMed ID: 8649370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biomechanical signals upregulate myogenic gene induction in the presence or absence of inflammation.
    Chandran R; Knobloch TJ; Anghelina M; Agarwal S
    Am J Physiol Cell Physiol; 2007 Jul; 293(1):C267-76. PubMed ID: 17392379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphorylation and alternative pre-mRNA splicing converge to regulate myocyte enhancer factor 2C activity.
    Zhu B; Gulick T
    Mol Cell Biol; 2004 Sep; 24(18):8264-75. PubMed ID: 15340086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mirk/dyrk1B decreases the nuclear accumulation of class II histone deacetylases during skeletal muscle differentiation.
    Deng X; Ewton DZ; Mercer SE; Friedman E
    J Biol Chem; 2005 Feb; 280(6):4894-905. PubMed ID: 15546868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. mef2c is activated directly by myogenic basic helix-loop-helix proteins during skeletal muscle development in vivo.
    Dodou E; Xu SM; Black BL
    Mech Dev; 2003 Sep; 120(9):1021-32. PubMed ID: 14550531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myocyte enhancer factor 2 acetylation by p300 enhances its DNA binding activity, transcriptional activity, and myogenic differentiation.
    Ma K; Chan JK; Zhu G; Wu Z
    Mol Cell Biol; 2005 May; 25(9):3575-82. PubMed ID: 15831463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activated notch inhibits myogenic activity of the MADS-Box transcription factor myocyte enhancer factor 2C.
    Wilson-Rawls J; Molkentin JD; Black BL; Olson EN
    Mol Cell Biol; 1999 Apr; 19(4):2853-62. PubMed ID: 10082551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MyoD and myogenin expression patterns in cultures of fetal and adult chicken myoblasts.
    Yablonka-Reuveni Z; Paterson BM
    J Histochem Cytochem; 2001 Apr; 49(4):455-62. PubMed ID: 11259448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AVP induces myogenesis through the transcriptional activation of the myocyte enhancer factor 2.
    Scicchitano BM; Spath L; Musarò A; Molinaro M; Adamo S; Nervi C
    Mol Endocrinol; 2002 Jun; 16(6):1407-16. PubMed ID: 12040025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MEF2C DNA-binding activity is inhibited through its interaction with the regulatory protein Ki-1/57.
    Kobarg CB; Kobarg J; Crosara-Alberto DP; Theizen TH; Franchini KG
    FEBS Lett; 2005 May; 579(12):2615-22. PubMed ID: 15862299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.